Literature DB >> 8463293

Transepithelial glycylsarcosine transport in intestinal Caco-2 cells mediated by expression of H(+)-coupled carriers at both apical and basal membranes.

D T Thwaites1, C D Brown, B H Hirst, N L Simmons.   

Abstract

Glycylsarcosine (Gly-Sar) transport in human intestinal epithelial (Caco-2) cells has been investigated. Gly-Sar transport, from apical to basal surfaces (Ja-b), and intracellular accumulation are greatest when the apical medium is acidified (apical pH 6.0, basal pH 7.4). Both transport and accumulation are susceptible to saturation and competition. Similarly, Gly-Sar transport, from basal to apical surfaces (Jb-a), is increased with acidification of the basal medium (basal pH 6.0, apical pH 7.4). Apical addition of 20 mM Gly-Sar (pH 6.0) to Caco-2 cell monolayers loaded with the pH indicator BCECF (2',7'-bis(2-carboxyethyl)-5-(6)-carboxyfluorescein) caused a marked cytosolic acidification. Basolateral application of 20 mM Gly-Sar (pH 6.0) also caused a fall in intracellular pH. These observations are consistent with the expression of H(+)-coupled dipeptide transporters at both membrane faces of the human intestinal epithelial Caco-2 cell line. We also provide direct evidence for dipeptide-stimulated H(+)-influx, across both apical and basolateral membranes, in this intact epithelial cell system.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8463293

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  50 in total

1.  H(+)/solute-induced intracellular acidification leads to selective activation of apical Na(+)/H(+) exchange in human intestinal epithelial cells.

Authors:  D T Thwaites; D Ford; M Glanville; N L Simmons
Journal:  J Clin Invest       Date:  1999-09       Impact factor: 14.808

2.  Function and immunolocalization of overexpressed human intestinal H+/peptide cotransporter in adenovirus-transduced Caco-2 cells.

Authors:  C P Hsu; E Walter; H P Merkle; B Rothen-Rutishauser; H Wunderli-Allenspach; J M Hilfinger; G L Amidon
Journal:  AAPS PharmSci       Date:  1999

3.  An improved cell culture model based on 2/4/A1 cell monolayers for studies of intestinal drug transport: characterization of transport routes.

Authors:  Staffan Tavelin; Jan Taipalensuu; Finn Hallböök; Kati-Sisko Vellonen; Vanessa Moore; Per Artursson
Journal:  Pharm Res       Date:  2003-03       Impact factor: 4.200

4.  Prediction of glycylsarcosine transport in Caco-2 cell lines expressing PEPT1 at different levels.

Authors:  Megumi Irie; Tomohiro Terada; Masahiro Tsuda; Toshiya Katsura; Ken-Ichi Inui
Journal:  Pflugers Arch       Date:  2005-11-10       Impact factor: 3.657

Review 5.  Carrier-mediated intestinal transport of drugs.

Authors:  A Tsuji; I Tamai
Journal:  Pharm Res       Date:  1996-07       Impact factor: 4.200

6.  Transport of the antibacterial agent oxazolidin-2-one and derivatives across intestinal (Caco-2) and renal (MDCK) epithelial cell lines.

Authors:  G Ranaldi; P Seneci; W Guba; K Islam; Y Sambuy
Journal:  Antimicrob Agents Chemother       Date:  1996-03       Impact factor: 5.191

7.  Differential effects of mucosal pH on human (Caco-2) intestinal epithelial cell motility, proliferation, and differentiation.

Authors:  D A Perdikis; R Davies; A Zhuravkov; B Brenner; L Etter; M D Basson
Journal:  Dig Dis Sci       Date:  1998-07       Impact factor: 3.199

8.  Transepithelial transport of the fluoroquinolone ciprofloxacin by human airway epithelial Calu-3 cells.

Authors:  M E Cavet; M West; N L Simmons
Journal:  Antimicrob Agents Chemother       Date:  1997-12       Impact factor: 5.191

9.  Peptide prodrugs: improved oral absorption of lopinavir, a HIV protease inhibitor.

Authors:  Sheetal Agarwal; S H S Boddu; Ritesh Jain; Swapan Samanta; Dhananjay Pal; Ashim K Mitra
Journal:  Int J Pharm       Date:  2008-03-28       Impact factor: 5.875

10.  Regulation of intracellular pH during H+-coupled oligopeptide absorption in enterocytes from guinea-pig ileum.

Authors:  H Hayashi; Y Suzuki
Journal:  J Physiol       Date:  1998-09-01       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.